Ziconotide

DRUG7 trials

Sponsors

Neurex, Elan Pharmaceuticals, National Cancer Institute, Naples, University Hospital, Linkoeping, Jazz Pharmaceuticals

Conditions

CancerChemotherapy Induced Peripheral Neuropathy (CIPN)HIV InfectionsIntractable PainNeuropathic PainPainPainful MyelopathyPainful Neuropathy

Phase 2

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

CompletedNCT00002160

NeurexCancer, HIV Infections, Pain

Target: 100Updated: 2005-06-24

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer

National Cancer Institute, NaplesCancer, Intractable Pain, Neuropathic Pain +1

Start: 2009-09-30End: 2024-12-31Target: 16Updated: 2023-03-24

Phase 3

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

CompletedNCT00076544

Elan PharmaceuticalsPain

Start: 2004-02-29Target: 300Updated: 2015-12-14

Phase 4

Intrathecal Bolus Doses of Ziconotide

CompletedNCT01373983

University Hospital, LinkoepingPeripheral Neuropathy

Start: 2011-08-31End: 2014-12-31Updated: 2014-12-30

Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy

WithdrawnNCT01992562

Aaron BosterPainful Myelopathy, Painful Neuropathy

Start: 2014-01-31End: 2015-12-31Updated: 2018-09-18

Unknown Phase

Patient Registry of Intrathecal Ziconotide Management(PRIZM)

CompletedNCT01888120

Jazz PharmaceuticalsPatients With Severe Chronic Pain

Start: 2013-07-31End: 2017-03-31Updated: 2017-03-16

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Not yet recruitingNCT07499882

Christian Hospital Northeast NorthwestChemotherapy Induced Peripheral Neuropathy (CIPN)

Start: 2026-05-02End: 2028-05-01Target: 24Updated: 2026-03-30

Related Papers

The inflammatory profile of cerebrospinal fluid, plasma, and saliva from patients with severe neuropathic pain and healthy controls-a pilot study.

2021-02-0128 citations